ATE550033T1 - Fusionsproteine des reproduktiven und respiratorischen syndrom virus aus dem schwein als prrs impfstoff - Google Patents

Fusionsproteine des reproduktiven und respiratorischen syndrom virus aus dem schwein als prrs impfstoff

Info

Publication number: ATE550033T1
Authority: AT; Austria
Prior art keywords: pqgab; prrsv; kdel; vaccine; pork
Prior art date: 2006-07-29

Application number

AT06253982T

Other languages

English (en)

Inventor

Hsiu-Kang Chang

Chao-Wei Liao

Original Assignee

Healthbanks Biotech Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-07-29

Filing date

2006-07-29

Publication date

2012-04-15

2006-07-29 Application filed by Healthbanks Biotech Co Ltd filed Critical Healthbanks Biotech Co Ltd

2012-04-15 Application granted granted Critical

2012-04-15 Publication of ATE550033T1 publication Critical patent/ATE550033T1/de

Links

229960005486 vaccine Drugs 0.000 title abstract 3
108020001507 fusion proteins Proteins 0.000 title abstract 2
102000037865 fusion proteins Human genes 0.000 title abstract 2
208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 title 1
241000700605 Viruses Species 0.000 title 1
235000015277 pork Nutrition 0.000 title 1
230000001850 reproductive effect Effects 0.000 title 1
230000000241 respiratory effect Effects 0.000 title 1
208000011580 syndromic disease Diseases 0.000 title 1
241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 abstract 2
206010020751 Hypersensitivity Diseases 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
101710087110 ORF6 protein Proteins 0.000 abstract 1
101900328733 Porcine reproductive and respiratory syndrome virus Glycoprotein 5 Proteins 0.000 abstract 1
108700033844 Pseudomonas aeruginosa toxA Proteins 0.000 abstract 1
101710095001 Uncharacterized protein in nifU 5'region Proteins 0.000 abstract 1
208000026935 allergic disease Diseases 0.000 abstract 1
230000007815 allergy Effects 0.000 abstract 1
239000000427 antigen Substances 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000000763 evoking effect Effects 0.000 abstract 1
238000002474 experimental method Methods 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
210000004072 lung Anatomy 0.000 abstract 1
238000006386 neutralization reaction Methods 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
229940031626 subunit vaccine Drugs 0.000 abstract 1
230000005945 translocation Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/04—Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10071—Demonstrated in vivo effect

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT06253982T 2006-07-29 2006-07-29 Fusionsproteine des reproduktiven und respiratorischen syndrom virus aus dem schwein als prrs impfstoff ATE550033T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP06253982A EP1882478B1 (de)	2006-07-29	2006-07-29	Fusionsproteine des reproduktiven und respiratorischen Syndrom Virus aus dem Schwein als PRRS Impfstoff

Publications (1)

Publication Number	Publication Date
ATE550033T1 true ATE550033T1 (de)	2012-04-15

Family

ID=37517616

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06253982T ATE550033T1 (de)	2006-07-29	2006-07-29	Fusionsproteine des reproduktiven und respiratorischen syndrom virus aus dem schwein als prrs impfstoff

Country Status (3)

Country	Link
EP (1)	EP1882478B1 (de)
AT (1)	ATE550033T1 (de)
ES (1)	ES2384524T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI417385B (zh) *	2010-05-04	2013-12-01	Univ Nat Taiwan	以植物生產之豬生殖與呼吸道綜合症口服疫苗及其用途
US11246915B2 (en)	2010-09-15	2022-02-15	Applied Molecular Transport Inc.	Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
CA2985381C (en)	2015-06-01	2020-03-24	Reber Genetics Co., Ltd.	Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases
PL3762009T3 (pl)	2018-03-08	2022-09-12	Applied Molecular Transport Inc.	Pochodzące z toksyny konstrukty dostarczające do dostarczania doustnego
SG11202104734YA (en)	2018-11-07	2021-06-29	Applied Molecular Transport Inc	Cholix-derived carriers for oral delivery of heterologous payload
CN113046329B (zh) *	2020-11-10	2024-01-30	山东省滨州畜牧兽医研究院	猪繁殖与呼吸障碍综合征病毒嵌合重组的PRRSV DIVA疫苗株cDY56

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7335361B2 (en) *	2003-06-09	2008-02-26	Animal Technology Institute Taiwan	Fusion antigen used as vaccine

2006
- 2006-07-29 AT AT06253982T patent/ATE550033T1/de active
- 2006-07-29 ES ES06253982T patent/ES2384524T3/es not_active Expired - Lifetime
- 2006-07-29 EP EP06253982A patent/EP1882478B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ES2384524T3 (es)	2012-07-06
EP1882478A1 (de)	2008-01-30
EP1882478B1 (de)	2012-03-21

Similar Documents

Publication	Publication Date	Title
CA2572555A1 (en)	2008-01-05	Fusion protein of porcine reproductive and respiratory syndrome virus as prrs vaccine
CY1123952T1 (el)	2022-03-24	Απομονωση και καθαρισμος αντισωματων αντι-il-13 με την χρηση χρωματογραφιας χημικης συγγενειας πρωτεινης α
WO2010074575A3 (en)	2010-08-26	Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv.
NZ600732A (en)	2014-06-27	Oxyntomodulin peptide analogue
RU2015122368A (ru)	2017-01-13	Слитые белки для применения в качестве иммуногенных усиливающих агентов для индуцирования антигенспецифического т-клеточного ответа
JP2009537143A5 (de)	2010-07-15
WO2002012281A3 (en)	2003-07-10	Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
MX2014007894A (es)	2014-09-26	Vacuna de marcadores basados en peptidos sinteticos y sistema de diagnostico para el control efectivo del sindrome reproductivo y respiratorio porcino (prrs).
WO2005081716A3 (en)	2009-04-02	DNA VACCINES TARGETING ANTIGENS OF THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-CoV)
ATE365746T1 (de)	2007-07-15	Prrsv-antigene, die auf peptidsequenzen des prrs- virus basieren, für die verwendung als impfstoff und für diagnostische tests
JP2011500035A5 (de)	2012-02-02
HRP20160020T1 (hr)	2016-02-12	Postupak za aktiviranje pomagaäśke t stanice i pripravak za uporabu u postupku
ME02600B (de)	2017-06-20	Immunogene zusammensetzung
WO2005120565A3 (en)	2007-05-18	Sars vaccines and methods to produce highly potent antibodies
WO2007098717A3 (es)	2007-11-01	Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
JP2016504993A5 (de)	2017-02-02
WO2022032660A1 (zh)	2022-02-17	新型冠状病毒rbd融合蛋白
CA2985381A1 (en)	2016-12-08	Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases
DK1687267T3 (da)	2012-01-23	Modificeret MscL-proteinkanal
AR071635A1 (es)	2010-06-30	Variantes de crig (receptor asociado a macrofagos) que tienen afinidad de union aumentada a c3b, con union selectiva sobre c3 (ambas proteinas del complemento).
ATE480569T1 (de)	2010-09-15	Zusammensetzungen und verfahren zur verabreichung anti-aktivierter ras-antikörper an zellen
Charron et al.	2026	Simultaneous modification of Thermotoga maritima encapsulin subunits to produce multivalent nanoparticle vaccines for non‐typhoidal Salmonella enterica
ATE356140T1 (de)	2007-03-15	Gd3 mimetische peptide
Alexander et al.	2017	CBirTox is a selective antigen-specific agonist of the Treg-IgA-microbiota homeostatic pathway
MX2011004176A (es)	2011-09-21	Peptido-epitope rab6kifl/kif20a y vacunas que contienen el mismo.